Biodefense Market Worth $22.8 Billion By 2030 | CAGR: 5.0%

December 2022 | Report Format: Electronic (PDF)

Biodefense Market Growth & Trends

The global biodefense market size is expected to reach USD 22.8 billion by 2030, and it is set to expand at 5.0% CAGR from 2022 to 2030, according to a new report by Grand View Research, Inc. Biodefense can be briefly defined as a set of comprehensive measures (identification, planning, and preparedness) undertaken to restore the biosecurity of a country.

It aims to tackle key biological threats or infectious diseases that can be easily used as a bioweapon to instigate social unrest and bioterrorism. Biological threats can be natural, accidental, or deliberate in origin and in all forms, present a grave threat. Factors like the presence of favorable government initiatives, increasing investment by private players, and the growing prevalence of various viral agents are fueling market growth.

Previous incidents of bioterrorism caused by viral agents like anthrax, smallpox, and botulism have made Biodefense a major focus area. The increased need for advancements for countries to defend themselves against grave threats remains the primary driver of growth. In 2017, the Centers for Disease Control and Prevention (CDC) stated that they had tracked more than 170 unique diseases, and outbreaks in more than 190 countries.

According to WHO, around 6,50,000 people die of respiratory diseases associated with seasonal flu annually. Repeated outbreaks of Zika and Ebola virus have coerced state governments to construct and strategize biodefense programs. These new programs will assist in planning and response during future outbreaks.

In 2018, the U.S. government announced a national biodefense strategy to manage the risk of biological threats. The new strategy can detect and contain bio-threats at its source, while simultaneously promoting biomedical innovation, and improving emergency response. These factors are expected to boost market growth.


key Request a free sample copy or view report summary: Biodefense Market Report


Biodefense Market Report Highlights

  • The anthrax segment dominated the market in 2022. These bioagents can last longer in the environment, and are released with ease, posing a high potential risk

  • The other segment is expected to register the highest CAGR during the forecast period. This segment includes potential threats such as zika, Ebola, and Marburg’s virus. The rising incidents of related outbreaks remain the key growth driver

  • North America is expected to dominate the global market during the forecast period, owing to the presence of high federal funding, technological advancements, and growing awareness among the population

Biodefense Market Segmentation

Grand View Research has segmented the global biodefense market based on product and region:

Biodefense Product Outlook (Revenue, USD Million, 2018 - 2030)

  • Anthrax

  • Smallpox

  • Botulism

  • Radiation/Nuclear

  • Others

Biodefense Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

List of Key Players of Biodefense Market

  • XOMA corporation

  • Altimmune Inc.

  • Emergent Biosolutions Inc.

  • Dynavax Technologies Corporation.

  • SIGA Technologies.

  • Elusys Therapeutics Inc.

  • Ichor Medical Systems.

  • Dynport Vaccine Company.

  • Cleveland Biolabs.

  • Bavarian Nordic.

  • Ology Bioservices.

  • Alnylam Pharmaceuticals Inc

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.